BOSTON, 20 December 2021 / PRNewswire / – Benjamin Franklin Institute of Technology (BFIT), a private, non-profit university providing affordable education for people seeking technical and business careers, today announced a partnership with Ginkgo Bioworks (NYSE: DNA) to develop an associate’s degree in manufacturing biotechnology. The program will be hosted at the Nubian Square Life Science Training Center, a collaboration of organizations coming together to meet the demand for a well-trained and diverse life sciences workforce, with additional funding through of a $ 100,000 grant from the Kargman Family Foundation.
The training partnership between BFIT and Ginkgo Bioworks, the leading horizontal platform for cell programming, will focus on supporting the development of essential workforce skills in the areas of biotechnology, bioproduction, clinical research and bioengineering. Graduates of the program will be prepared and trained for a wide range of entry-level and intermediate technician positions focused on operations and maintenance, positions in high demand in the life sciences field. A Massachusetts Biotechnology Education Foundation Report 2020 shows a 67% increase in life science jobs in Massachusetts during the last decade. The report also found that at the level of associate’s and high school graduates, the demand for employment increased by 140%.
“Our partnership with Ginkgo Bioworks is another example of BFIT’s agile approach to identifying high-demand industries that require a skilled workforce and provide sustainable career development opportunities for our graduates,” said Aïcha Francois, President and CEO of BFIT. “This new associate’s degree in biotechnology manufacturing enables our students to play a vital role in providing a diverse and skilled workforce to fill. Massachusetts’ booming life sciences and medical industry. “
“There is a common misconception that only graduates with higher degrees are qualified for jobs in the life sciences. It is time for this misconception to be corrected,” said Reshma shetty, co-founder, COO and president of Ginkgo Bioworks. “BFIT has strong community ties and a reputation for successfully educating young people in technical careers, and Ginkgo is committed to training the next generation of life science professionals. Through this partnership, we hope to create long term career opportunities for people who may not have already considered this field.
The Nubian Square Life Sciences Training Center is located near Madison Park Vocational Technical High School, John D. O’Bryant School of Mathematics and Science, Dearborn STEM Academy, Roxbury Community College, and other academic institutions with young talent eager to prepare for careers in the life sciences. A key catalyst for this curriculum will be the Nubian Square Life Sciences Training Center, located at Ascension of Nubia in the Roxbury neighborhood adjacent to the state-of-the-art 68,000 square foot BFIT campus, planned at the corner of Harrison Avenue and Eustis Street, remodeling the landscape and adding economic vitality to this historically and culturally rich region. The training center will be designed to include laboratory training facilities; BFIT instructors will provide instruction for talented students studying to enter these growing industries.
“We have entered into this strategic education partnership with partner companies to ensure that community members in historically neglected regions have access to new economy jobs that are in high demand and well paying. This is what equity looks like in action and it is long overdue. ,” noted Richard taylor, general manager of the Nubian Ascends project.
The Nubian Square Life Sciences Training Center has already received a $ 100,000 grant from the Kargman Family Foundation to educate and explain career options in the life sciences to high school students, community college students and adults looking for a new career in Boston.
On Benjamin Franklin Institute of Technology
Founded in 1908 in Boston, Benjamin Franklin Institute of Technology is an affordable urban college serving the Boston region and committed to the success of students and their preparation for careers in technological fields, 90% of which are integrated with a sustainability approach. With clean and green technology verticals in their best agendas such as HVAC & R, Wind Power Technology, Automotive and Electrical Engineering, BFIT provides personalized support, hands-on learning and industry-tailored study programs for prepare graduates for well-paid work, lifelong learning and civic engagement. For more information, please visit www.bfit.edu.
About Ginkgo Bioworks
Ginkgo is building a platform to allow customers to program cells as easily as we can program computers. The company’s platform enables biotechnology applications in a variety of markets, from food and agriculture to industrial chemicals and pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including pooled K-12 testing, optimization of vaccine manufacturing, and discovery of therapies. For more information visit www.ginkgobioworks.com.
About Nubian Ascends
In addition to the life sciences training center, the Nubian Ascends project will provide affordable artist housing, artist studios and collaboration spaces, commercial spaces, a market, 300 car parking and a hall. versatile cultural center and a theater that will support the transformation of Nubia Square into a new emblematic space of the region. The proposed commercial space will promote job creation, which will bring purchasing power to support neighborhood businesses and create demand for the 48,000 sq. Ft. Market on the ground floor. The market will feature local artisans and manufacturers and a food hall that features chefs from an on-site culinary arts program. www.nubiansquareascends.com
Ginkgo Bioworks forward-looking statements
This press release contains certain forward-looking statements within the meaning of federal securities laws, including statements regarding the potential success of the partnership and Ginkgo’s cellular programming platform. These forward-looking statements are generally identified by the words “believe”, “plan”, “potential”, “expect”, “anticipate”, “estimate”, “intend”, “the strategy”, “l ‘future’, ‘opportunity,’ ‘plan’, ‘may’, ‘should’, ‘will’, ‘would’, ‘will’, ‘will continue’, ‘will likely result’, and similar expressions. Forward-looking statements are predictions, projections and other statements regarding future events that are based on current expectations and assumptions and, therefore, are subject to risks and uncertainties. There are many factors that could cause actual future events to differ materially from the forward-looking statements contained in this document, including, but not limited to: (i) the effect of the business combination with Soaring Eagle Acquisition Corp. (“Soaring Eagle”) on Ginkgo’s business relations, performance and business in general, (ii) the risks that the business combination disrupts Ginkgo’s current plans and potential difficulties in retaining Ginkgo employees, ( iii) the outcome of any legal proceedings that may be brought against Ginkgo relating to its business combination with Soaring Eagle, (iv) volatility in the price of Ginkgo shares now that it is a public company due to various factors, including changes in the competitive and highly regulated industries in which Ginkgo plans to operate, variations in performance between competitors, changes in laws and regulations affecting Ginkgo’s business and changes in the combined capital structure , (v) the ability to implement activities p plans, forecasts and other expectations after the completion of the business combination, and identify and realize additional opportunities, and (vi) the risk of declining demand for products using synthetic biology. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of Ginkgo’s Quarterly Report on Form 10-Q filed with the United States Securities and Exchange Commission (the “SEC” ) the November 15, 2021 and other documents filed by Ginkgo from time to time with the SEC. These documents identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in forward-looking statements. Forward-looking statements speak only as of the date on which they are made. Readers are cautioned not to place undue reliance on forward-looking statements, and Ginkgo assumes no obligation and does not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Ginkgo gives no assurance that he will meet his expectations.
GINKGO BIOWORKS INVESTOR CONTACT:
GINKGO BIOWORKS MEDIA CONTACT:
SOURCE Ginkgo Bioworks